The unusual mechanism of MET inhibition by 107_A07, involving biochemical competition for ligand binding despite clear separation of binding footprints, contrasts with this of onartuzumab and illuminates all of the potential mechanisms by which antibody-mediated MET inhibition may be accomplished
The unusual mechanism of MET inhibition by 107_A07, involving biochemical competition for ligand binding despite clear separation of binding footprints, contrasts with this of onartuzumab and illuminates all of the potential mechanisms by which antibody-mediated MET inhibition may be accomplished. Electronic supplementary material Supplementary Details(3.8M, pdf) Acknowledgements The crystallographic work was performed in the Crystallographic…